Wells Fargo’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-207,270
Closed -$871K 7849
2023
Q1
$871K Buy
+207,270
New +$1.08M ﹤0.01% 3473
2022
Q4
Sell
-7,426
Closed -$43K 8042
2022
Q3
$43K Buy
7,426
+1,575
+27% +$9.81K ﹤0.01% 5026
2022
Q2
$35K Buy
5,851
+5,351
+1,070% +$27.4K ﹤0.01% 5196
2022
Q1
$2K Sell
500
-17
-3% -$51 ﹤0.01% 6737
2021
Q4
$1K Buy
517
+1
+0.2% +$2 ﹤0.01% 7151
2021
Q3
$2K Sell
516
-27
-5% -$74 ﹤0.01% 6636
2021
Q2
$1K Buy
543
+166
+44% +$398 ﹤0.01% 6829
2021
Q1
$1K Sell
377
-48,533
-99% -$158K ﹤0.01% 6835
2020
Q4
$157K Buy
48,910
+48,562
+13,955% +$162K ﹤0.01% 5184
2020
Q3
$1K Sell
348
-260
-43% -$332 ﹤0.01% 6272
2020
Q2
$1K Buy
608
+158
+35% +$167 ﹤0.01% 6229
2020
Q1
$0 Buy
+450
New +$516 ﹤0.01% 7408
2019
Q3
Sell
-2,425
Closed -$2K 7117
2019
Q2
$2K Sell
2,425
-140,674
-98% -$130K ﹤0.01% 6218
2019
Q1
$138K Sell
143,099
-14,070
-9% -$14.8K ﹤0.01% 5006
2018
Q4
$115K Buy
157,169
+102,605
+188% +$169K ﹤0.01% 5221
2018
Q3
$118K Buy
54,564
+1,335
+3% +$3.31K ﹤0.01% 5283
2018
Q2
$265K Buy
53,229
+24,966
+88% +$109K ﹤0.01% 4879
2018
Q1
$111K Buy
28,263
+231
+0.8% +$812 ﹤0.01% 5262
2017
Q4
$75K Buy
+28,032
New +$82.2K ﹤0.01% 5419
2017
Q3
Sell
-23
Closed 6744
2017
Q2
$0 Sell
23
-2
-8% -$8 ﹤0.01% 6781
2017
Q1
$0 Hold
25
﹤0.01% 6818
2016
Q4
$0 Buy
25
+2
+9% +$8 ﹤0.01% 6761
2016
Q3
$0 Hold
23
﹤0.01% 6670
2016
Q2
$0 Sell
23
-6,847
-100% -$31.4K ﹤0.01% 6728
2016
Q1
$37K Sell
6,870
-957
-12% -$7.65K ﹤0.01% 5335
2015
Q4
$96K Sell
7,827
-19
-0.2% -$254 ﹤0.01% 4937
2015
Q3
$115K Sell
7,846
-1,102
-12% -$19K ﹤0.01% 4790
2015
Q2
$175K Buy
8,948
+5,160
+136% +$99.6K ﹤0.01% 4685
2015
Q1
$68K Buy
3,788
+3,166
+509% +$71.3K ﹤0.01% 4903
2014
Q4
$15K Buy
622
+5
+0.8% +$116 ﹤0.01% 5490
2014
Q3
$15K Sell
617
-337
-35% -$8.76K ﹤0.01% 5444
2014
Q2
$27K Buy
954
+754
+377% +$22.7K ﹤0.01% 5246
2014
Q1
$7K Buy
+200
New +$6.83K ﹤0.01% 5493

Other funds holding CTIC